Which country? [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2019-09-09 23:17 (337 d 15:47 ago) – Posting: # 20566
Views: 4,495

Hi Elena,

» We are planning to conduct several BE studies with adaptive design using the drugs with uncertain intraCV. We have decided to use method C described by Potvin …

Whether Potvin’s Method C will be accepted depends on the jurisdiction you are bound to.a,b
More information please.


  1. Accepted by the FDA (Donald Schuirmann is a co-author of this paper and later ones) and Health Canada. Confirmed at the 2nd/3rd GBHI conferences (Rockville 2016, Amsterdam 2018) that any simulation-based method is acceptable.
  2. For the EMA possible if BE already in stage 1, difficult if you proceeded to stage 2. Even Method B is tricky. The EMA dislikes (oh dear!) methods based on simulations and prefers ones which showed strict control of the type I error, i.e.,
    1. König F, Wolfsegger M, Jaki T, Schütz H, Wassmer G. Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation. Vienna: 2014; 35th Annual Conference of the International Society for Clinical Biostatistics. Poster P1.2.88. doi:10.13140/RG.2.1.5190.0967.
    2. Maurer W, Jones B, Chen Y. Controlling the type 1 error rate in two-stage sequential designs when testing for average bioequivalence. Stat Med. 2018;37(10):1–21. doi:10.1002/sim.7614.
    BTW, implemented in the [image]-package Power2Stage: functions power.2stage.in(), interim.tsd.in(), final.tsd.in() since October 2017.
    The EMA’s Pharmacokinetics Working Party and the Biostatistics Working Party had two-stage design on their workplan for years (!) with any outcome. At last year’s BioBridges Paola Cop­pola (MHRA) showed this slide:

    [image]

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,006 posts in 4,379 threads, 1,460 registered users;
online 11 (2 registered, 9 guests [including 4 identified bots]).
Forum time: Wednesday 15:05 CEST (Europe/Vienna)

Statistics is the art of never having to say you’re wrong.
Variance is what any two statisticians are at.    C.J. Bradfield

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5